Caribou Biosciences, Inc. Increase (Decrease) in Contract with Customer, Asset
Caribou Biosciences, Inc. (CRBU) reported Increase (Decrease) in Contract with Customer, Asset of -$403.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerAsset · last filed 2026-08-13
- Caribou Biosciences, Inc. increase (decrease) in contract with customer, asset for the quarter ending 2026-06-30 was -$88.00K.
- Caribou Biosciences, Inc. increase (decrease) in contract with customer, asset for the quarter ending 2026-03-31 was -$315.00K.
- Caribou Biosciences, Inc. increase (decrease) in contract with customer, asset for the quarter ending 2025-12-31 was $146.00K, a 59.56% decline year-over-year.
- Caribou Biosciences, Inc. increase (decrease) in contract with customer, asset for the quarter ending 2025-09-30 was $107.00K.
- Caribou Biosciences, Inc. increase (decrease) in contract with customer, asset for fiscal 2025 was -$152.00K.
- Caribou Biosciences, Inc. increase (decrease) in contract with customer, asset for fiscal 2024 was -$267.00K.
- Caribou Biosciences, Inc. increase (decrease) in contract with customer, asset for fiscal 2023 was -$822.00K, a 208.30% decline from fiscal 2022.
- Caribou Biosciences, Inc. increase (decrease) in contract with customer, asset for fiscal 2022 was $759.00K, a 374.38% increase from fiscal 2021.
| Period end | Increase (Decrease) in Contract with Customer, Asset 3 month | Increase (Decrease) in Contract with Customer, Asset 6 month | Increase (Decrease) in Contract with Customer, Asset 9 month | Increase (Decrease) in Contract with Customer, Asset 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$403.00K 10-Q · filed 2026-08-13 | -$257.00K derived: sum of 3 quarters · filed 2026-08-13 | -$150.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$315.00K 10-Q · filed 2026-05-07 | -$169.00K derived: sum of 2 quarters · filed 2026-05-07 | -$62.00K derived: sum of 3 quarters · filed 2026-05-07 | -$117.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $253.00K derived: sum of 2 quarters · filed 2026-03-05 | $198.00K derived: sum of 3 quarters · filed 2026-08-13 | -$152.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $52.00K derived: sum of 2 quarters · filed 2026-08-13 | -$298.00K 10-Q · filed 2025-11-12 | $63.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$405.00K 10-Q · filed 2026-08-13 | -$44.00K derived: sum of 3 quarters · filed 2026-08-13 | -$219.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$350.00K 10-Q · filed 2026-05-07 | $11.00K derived: sum of 2 quarters · filed 2026-05-07 | -$164.00K derived: sum of 3 quarters · filed 2026-05-07 | -$163.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $361.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $186.00K derived: sum of 2 quarters · filed 2026-03-05 | $187.00K derived: sum of 3 quarters · filed 2026-03-05 | -$267.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | -$175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$174.00K derived: sum of 2 quarters · filed 2025-11-12 | -$628.00K 10-Q · filed 2025-11-12 | -$862.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$453.00K 10-Q · filed 2025-08-12 | -$687.00K derived: sum of 3 quarters · filed 2025-08-12 | -$510.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$454.00K 10-Q · filed 2025-05-08 | -$688.00K derived: sum of 2 quarters · filed 2025-05-08 | -$511.00K derived: sum of 3 quarters · filed 2025-05-08 | -$669.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$234.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -$57.00K derived: sum of 2 quarters · filed 2025-03-10 | -$215.00K derived: sum of 3 quarters · filed 2025-03-10 | -$822.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $177.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $19.00K derived: sum of 2 quarters · filed 2024-11-06 | -$588.00K 10-Q · filed 2024-11-06 | -$240.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$765.00K 10-Q · filed 2024-08-06 | -$417.00K derived: sum of 3 quarters · filed 2024-08-06 | -$612.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | -$607.00K 10-Q · filed 2024-05-07 | -$259.00K derived: sum of 2 quarters · filed 2024-05-07 | -$454.00K derived: sum of 3 quarters · filed 2024-05-07 | $146.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $348.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $153.00K derived: sum of 2 quarters · filed 2024-03-11 | $753.00K derived: sum of 3 quarters · filed 2024-03-11 | $759.00K 10-K · filed 2024-03-11 |
| 2022-09-30 | -$195.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $405.00K derived: sum of 2 quarters · filed 2023-11-07 | $411.00K 10-Q · filed 2023-11-07 | $46.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $606.00K 10-Q · filed 2023-08-08 | $241.00K derived: sum of 3 quarters · filed 2023-08-08 | $1.26M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $6.00K 10-Q · filed 2023-05-09 | -$359.00K derived: sum of 2 quarters · filed 2023-05-09 | $664.00K derived: sum of 3 quarters · filed 2023-05-09 | $521.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$365.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $658.00K derived: sum of 2 quarters · filed 2023-03-09 | $515.00K derived: sum of 3 quarters · filed 2023-03-09 | $160.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $880.00K derived: sum of 2 quarters · filed 2022-11-08 | $525.00K 10-Q · filed 2022-11-08 | $1.19M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$498.00K 10-Q · filed 2022-08-09 | $164.00K derived: sum of 3 quarters · filed 2022-08-09 | $409.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$355.00K 10-Q · filed 2022-05-09 | $307.00K derived: sum of 2 quarters · filed 2022-05-09 | $552.00K derived: sum of 3 quarters · filed 2022-05-09 | |
| 2020-12-31 | $662.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $907.00K derived: sum of 2 quarters · filed 2022-03-21 | $492.00K 10-K · filed 2022-03-21 | |
| 2020-09-30 | $245.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$170.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | -$415.00K 10-Q · filed 2021-09-02 | |||
| 2019-12-31 | $836.00K 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |